Previous studies have shown that soluble Aβ40, but not Aβ42, extracted from the frontal cortex of patients with AD gradually increases along with the progression of Braak scores, suggesting a specific link between Aβ40 levels and the progression of tau pathology [50]. The gene discussed is MAPT; the disease is Alzheimer disease.